TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says June 6, 2003
TCL Archive DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting March 12, 1982
TCL Archive NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected June 14, 1985
TCL Archive In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970 June 1, 1975
